 |
Morphic Therapeutic
Last updated: April 14, 2024
The team
Country: USA | Funding: $510.5M (+)
Website: https://morphictx.com
Morphic Therapeutic is developing oral, small-molecule formulations aimed at the family of common cell-surface receptors linked to inflammation, fibrosis, oncology and cardiometabolic disease.
Website: https://morphictx.com
Morphic Therapeutic is developing oral, small-molecule formulations aimed at the family of common cell-surface receptors linked to inflammation, fibrosis, oncology and cardiometabolic disease.
